Experts fear Trump’s unregulated use of the malaria drug is dangerous, and muddies the waters around research which could still find chloroquine useful in preventing SARS-CoV-2 infection.
President Trump has said he is taking hydroxychloroquine to help prevent him from catching COVID-19 – despite the fact that the drug is not approved for this use, and warnings from the US Food and Drug Administration that it can cause heart problems.
Speaking at the White House on 18 May, Trump told a press briefing that he had started taking the malaria and lupus medication recently
The Japanese drug maker is on track for three pivotal Phase III readouts and two regulatory submissions in 2025.
Neurocrine, Madrigal and Vanda updated investors on new drug launches, while Cytokinetics talked to investors about an FDA extension for aficamten.
Vaccine and accelerated approvals are expected to face greater scrutiny under new CBER leader Vinay Prasad, but he has promised “no light switch change” to policy, giving some reassurance to companies whose share prices have been battered.
